Mizuyama Yoko, Shinto Osamu, Matsutani Sinji, Arimoto Yuichi, Nakagawa Hiroji, Ohno Yoshioki, Takashima Tsutomu
Dept. of Surgery, Ohno Memorial Hospital.
Gan To Kagaku Ryoho. 2014 Nov;41(12):1962-4.
A morphological change resembling liver cirrhosis called pseudocirrhosis may be observed following chemotherapy for liver metastasis of breast cancer. Pseudocirrhosis is hypothesized to be caused by retraction of the hepatic capsule along with tumor shrinkage and subsequent scar formation around the metastatic lesion, as a response to the infiltrating tumor or chemotherapy-induced hepatic injury. The progression of cirrhotic changes may result in portal hypertension and esophageal varices. We managed two cases of esophageal variceal rupture during chemotherapy for breast cancer with liver metastasis. Hemostasis was successfully achieved by the endoscopic variceal ligation technique in both cases. We conclude that clinicians should be aware of the risk of pseudocirrhosis during chemotherapy for liver metastasis, and a periodic endoscopic follow-up is recommended along with appropriate management of esophageal varices.
在对乳腺癌肝转移进行化疗后,可能会观察到一种类似肝硬化的形态学变化,称为假性肝硬化。据推测,假性肝硬化是由于肝包膜随着肿瘤缩小而回缩,以及随后在转移病灶周围形成瘢痕,作为对浸润性肿瘤或化疗引起的肝损伤的一种反应。肝硬化变化的进展可能导致门静脉高压和食管静脉曲张。我们处理了两例乳腺癌肝转移化疗期间食管静脉曲张破裂的病例。两例均通过内镜下静脉曲张结扎术成功止血。我们得出结论,临床医生在对肝转移进行化疗期间应意识到假性肝硬化的风险,建议定期进行内镜随访并对食管静脉曲张进行适当处理。